Congenital urinary tract anomalies
·
Increasingly,
urinary tract anomalies are being detected earlier by the use of routine
antenatal ultrasound scans.
·
Renal
anomalies account for about 20% of all significant abnormalities found on
detailed scans at 18–20wks gestation.
·
Close
liaison between obstetricians, paediatrician, and surgeon with regard to
counselling the parents and follow-up is vital.
·
Centres
should have a postnatal investigation protocol as the majority of infants will
be asymptomatic.
·
Oligohydramnios: low urine production or
obstruction of urine excretion that
may lead to pulmonary hypoplasia.
·
Polyhydramnios: polyuria.
·
Enlarged: cystic kidneys (any cause);
hydronephrosis.
·
Small: dysplasia.
Unilateral:
pelviureteric junction (PUJ) or
vescioureteric junction (VUJ) obstruction;
vescioureteric reflux (VUR).
· Bilateral:
bladder outlet obstruction, e.g.
PUV, VUR, prune belly syndrome.
·
Multicystic
dysplastic kidneys (MCDK).
·
Polycystic
kidney disease (PCKD).
·
Cystic
dysplasia.
Echogenic:
·
cystic
kidneys (any cause);
·
congenital
nephrotic syndrome (may have polyhydramnios, large placenta).
If a major problem is suspected
(e.g. PUV, bilateral severe hydronephro-sis, palpable kidneys), a renal US
should be performed after 24hr of age. Otherwise routine postnatal
investigation with U/S (at 2–4wks), MCUG (at 4–8wks), and radionuclide scan (at
8–12wks of age).
In the postnatal period, ensure
male infants have voided and that a good urinary stream is observed. The
initial postnatal US finding guides further management.
·MCUG only routine if strong
suspicion of VUR (e.g. dilated ureters/ intermittent dilatation of pelvis).
Will need cover with antibiotics (e.g. oral trimethoprim) for the procedure.
·Give antibiotic prophylaxis (e.g.
oral trimethoprim) to all babies with suspicion of VUR.
·Radionuclide scan depends upon
lesion:
· DMSA if function of kidney
required (e.g. MCDK, VUR);
· MAG-3 renogram if ‘obstruction’
being evaluated (e.g. PUJ, VUJ).
Most infants with hydronephrosis
can be conservatively managed if they are asymptomatic.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.